Disease Name |
ICD 11 |
Studied Tissue |
p-value |
Fold-Change |
Z-score |
Acute myelocytic leukaemia
|
2B33.1 |
Bone marrow |
1.78E-09
|
3.14E-01
|
7.38E-01 |
Alzheimer's disease
|
8A20 |
Entorhinal cortex |
2.01E-03
|
9.42E-02
|
3.56E-01 |
Asthma
|
CA23 |
Nasal and bronchial airway |
2.87E-01
|
-2.08E-02
|
-2.94E-02 |
Behcet's disease
|
4A62 |
Peripheral blood |
8.39E-01
|
-7.56E-02
|
-1.48E-01 |
Bipolar disorder
|
6A60-6A6Z |
Prefrontal cortex |
5.23E-01
|
4.85E-02
|
1.23E-01 |
Bladder cancer
|
2C94 |
Bladder tissue |
2.51E-01
|
-4.39E-01
|
-7.94E-01 |
Breast cancer
|
2C60-2C6Z |
Breast tissue |
7.17E-28
|
-4.01E-01
|
-1.00E+00 |
Colon cancer
|
2B90 |
Colon tissue |
4.48E-84
|
-1.20E+00
|
-2.76E+00 |
Diffuse large B-cell lymphoma
|
2A81 |
Tonsil tissue |
2.12E-01
|
-2.90E-01
|
-2.03E+00 |
Familial hypercholesterolemia
|
5C80.00 |
Peripheral blood |
1.70E-01
|
-3.32E-01
|
-1.52E+00 |
Gastric cancer
|
2B72 |
Gastric tissue |
5.54E-01
|
-4.66E-01
|
-8.89E-01 |
Glioblastopma
|
2A00.00 |
Nervous tissue |
5.95E-08
|
-1.78E-01
|
-3.79E-01 |
Head and neck cancer
|
2D42 |
Head and neck tissue |
2.11E-08
|
-5.18E-01
|
-1.28E+00 |
HIV-associated neurocognitive impairment
|
8A2Y-8A2Z |
White matter tissue |
9.58E-01
|
-1.55E-01
|
-4.91E-01 |
Idiopathic pulmonary fibrosis
|
CB03.4 |
Lung tissue |
4.00E-01
|
1.95E-01
|
5.87E-01 |
Interstitial cystitis
|
GC00.3 |
Bladder tissue |
6.33E-01
|
-1.71E-01
|
-2.38E-01 |
Ischemic stroke
|
8B11 |
Peripheral blood |
2.82E-01
|
-4.86E-02
|
-7.39E-02 |
Liver cancer
|
2C12.0 |
Liver tissue |
8.31E-01
|
-1.43E-01
|
-2.25E-01 |
Liver failure
|
DB99.7-DB99.8 |
Liver tissue |
6.63E-01
|
1.06E-01
|
3.53E-01 |
Lung cancer
|
2C25 |
Lung tissue |
8.97E-10
|
-3.59E-01
|
-7.80E-01 |
Lupus erythematosus
|
4A40 |
Whole blood |
9.40E-01
|
-3.49E-02
|
-4.88E-02 |
Major depressive disorder
|
6A70-6A7Z |
Hippocampus |
5.24E-01
|
-1.05E-01
|
-2.63E-01 |
Multiple myeloma
|
2A83.1 |
Bone marrow |
9.48E-02
|
-1.02E-01
|
-9.52E-01 |
Multiple myeloma
|
2A83.1 |
Peripheral blood |
7.49E-01
|
4.83E-02
|
1.10E-01 |
Multiple sclerosis
|
8A40 |
Plasmacytoid dendritic cells |
9.67E-02
|
3.31E-01
|
5.15E-01 |
Myelodysplastic syndrome
|
2A36-2A3Z |
Bone marrow |
9.41E-02
|
8.87E-02
|
2.35E-01 |
Myocardial infarction
|
BA41-BA50 |
Peripheral blood |
3.35E-01
|
-4.99E-02
|
-5.72E-02 |
Neuroectodermal tumour
|
2A00.11 |
Brain stem tissue |
5.09E-09
|
-1.04E+00
|
-4.58E+00 |
Non-alcoholic fatty liver disease
|
DB92 |
Liver tissue |
6.61E-01
|
3.61E-02
|
1.27E-01 |
Obesity related type 2 diabetes
|
5A11 |
Omental adipose tissue |
1.85E-01
|
1.34E-01
|
7.87E-01 |
Olive pollen allergy
|
CA08.00 |
Peripheral blood |
8.30E-01
|
5.80E-02
|
3.27E-01 |
Oral cancer
|
2B6E |
Oral tissue |
3.74E-03
|
-5.34E-01
|
-1.20E+00 |
Ovarian cancer
|
2C73 |
Ovarian tissue |
2.45E-03
|
-1.34E+00
|
-1.96E+00 |
Pancreatic cancer
|
2C10 |
Pancreas |
1.09E-02
|
2.39E-01
|
6.64E-01 |
Parkinson's disease
|
8A00.0 |
Substantia nigra tissue |
4.00E-02
|
3.09E-01
|
1.35E+00 |
Pituitary cancer
|
2D12 |
Pituitary tissue |
2.04E-02
|
6.46E-01
|
1.60E+00 |
Polycystic ovary syndrome
|
5A80.1 |
Vastus lateralis muscle |
5.42E-01
|
9.73E-02
|
5.78E-01 |
Pompe disease
|
5C51.3 |
Biceps muscle |
2.74E-03
|
-4.33E-01
|
-1.22E+00 |
Prostate cancer
|
2C82 |
Prostate |
2.48E-01
|
-1.52E-02
|
-2.54E-02 |
Psoriasis
|
EA90 |
Skin |
6.10E-03
|
1.57E-01
|
3.40E-01 |
Rectal cancer
|
2B92 |
Rectal colon tissue |
7.78E-04
|
-1.38E+00
|
-2.99E+00 |
Renal cancer
|
2C90-2C91 |
Kidney |
3.36E-03
|
-4.16E-01
|
-9.90E-01 |
Retinoblastoma
|
2D02.2 |
Uvea |
8.95E-05
|
6.29E-01
|
2.01E+00 |
Schizophrenia
|
6A20 |
Prefrontal cortex |
7.74E-01
|
2.32E-02
|
6.10E-02 |
Schizophrenia
|
6A20 |
Superior temporal cortex |
5.06E-01
|
-3.38E-02
|
-1.79E-01 |
Scleroderma
|
4A42.Z |
Whole blood |
2.37E-01
|
-1.50E-01
|
-3.41E-01 |
Seizure
|
8A60-8A6Z |
Whole blood |
6.16E-01
|
1.18E-01
|
2.64E-01 |
Sepsis with septic shock
|
1G41 |
Whole blood |
5.04E-02
|
-8.80E-02
|
-2.38E-01 |
Sickle cell disease
|
3A51.0-3A51.3 |
Peripheral blood |
1.84E-01
|
1.19E-01
|
4.60E-01 |
Simpson golabi behmel syndrome
|
LD2C |
Adipose tissue |
8.35E-01
|
1.17E-01
|
3.84E-01 |
Sjogren's syndrome
|
4A43.2 |
Salivary gland tissue |
1.87E-01
|
6.46E-02
|
5.75E-01 |
Skin cancer
|
2C30-2C3Z |
Skin |
2.11E-10
|
4.20E-01
|
9.04E-01 |
Thrombocythemia
|
3B63 |
Whole blood |
3.44E-03
|
-2.71E-01
|
-8.85E-01 |
Thrombocytopenia
|
3B64 |
Whole blood |
9.70E-01
|
7.17E-01
|
5.55E-01 |
Thyroid cancer
|
2D10 |
Thyroid |
6.38E-17
|
-7.95E-01
|
-1.27E+00 |
Tibial muscular dystrophy
|
8C75 |
Muscle tissue |
4.10E-02
|
-2.26E-01
|
-4.56E-01 |
Tuberous sclerosis complex
|
LD2D.2 |
Perituberal tissue |
3.59E-01
|
-2.07E-01
|
-7.53E-01 |
Type 2 diabetes
|
5A11 |
Liver tissue |
9.95E-02
|
2.53E-01
|
1.09E+00 |
Ureter cancer
|
2C92 |
Urothelium |
9.18E-01
|
-6.35E-02
|
-3.20E-01 |
Uterine cancer
|
2C78 |
Endometrium tissue |
2.91E-13
|
-4.92E-01
|
-1.13E+00 |
Vitiligo
|
ED63.0 |
Skin |
2.49E-01
|
-1.45E-01
|
-4.17E-01 |
------------------------------------------------------------------------------------ |
|
|
|
|
|